Cryoport, Inc.

CYRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001124524

Price chart

Open-market purchases and sales by CYRX insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Aug 11, 20266:49 PM ETAug 11, 2026SHELTON JERRELLPresident, CEOSSaleCommon Stock−28.8K$14.9092−$429.38K1.2M−2.3%SEC10b5-1
Jun 12, 2026Jun 10 – Jun 11, 2026ZECCHINI EDWARD JChief Digital and Tech OfficerSSaleCommon Stock−35K$14.5004−$507.51K109.72K−24.2%SEC
Jun 8, 2026Jun 4, 2026STEFANOVICH ROBERTChief Financial OfficerSSaleCommon Stock−169.43K$16.27−$2.76M109.85K−60.7%SEC
Jun 8, 2026Jun 8, 2026Mandalam RamkumarDirectorSSaleCommon Stock−23.21K$15.44−$358.42K67.89K−25.5%SEC
Mar 25, 2026Mar 23, 2026STEFANOVICH ROBERTChief Financial OfficerSSaleCommon Stock−1.09K$8.18−$8.95K279.28K−0.4%SEC

The largest institutional positions in CYRX at the end of Q2 2026.

Institutions holding CYRX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.4,218,434$66.23M0.00%+237,536+6.0%Added
CADIAN CAPITAL MANAGEMENT, LP2,920,681$45.85M3.47%−1,855,662−38.9%Reduced
First Eagle Investment Management, LLC2,542,848$39.92M0.03%+1,797,999+241.4%Added
Assenagon Asset Management S.A.2,304,622$36.18M0.02%+808,939+54.1%Added
MORGAN STANLEY2,276,741$35.74M0.00%−2,299,989−50.3%Reduced